メニュを開く メニュ
文字サイズ 小 標準 大
ホーム / 診療科のご案内 / 呼吸器外科 / 英文論文業績一覧

英文論文業績一覧

論文業績（2016年度）

＜原著論文＞

  1. Goto T, Hirotsu Y, Oyama T, Amemiya K, Omata M.
    Analysis of tumor-derived DNA in plasma and bone marrow fluid in lung cancer patients.
    Med Oncol.2016 Mar;33(3):29.
  2. Amemiya K, Hirotsu Y, Goto T, Nakagomi H, Mochizuki H, Oyama T, Omata M.
    Touch imprint cytology with massively parallel sequencing (TIC-seq): a simple and rapid method to snapshot genetic alterations in tumors.
    Cancer Med. 2016 Dec;5(12):3426-3436.

論文業績（2017年度）

＜原著論文＞

  1. Yokoyama Y, Nakagomi T, Shikata D, Goto T.
    A novel technique for chest drain removal using a two layer method with triclosan-coated sutures.
    J Thorac Dis. 2017 Jan;9(1):211-213.
  2. Goto T, Hirotsu Y, Mochizuki H, Nakagomi T, Shikata D, Yokoyama Y, Oyama T, Amemiya K, Okimoto K, Omata M.
    Mutational analysis of multiple lung cancers: Discrimination between primary and metastatic lung cancers by genomic profile.
    Oncotarget. 2017 May 9;8(19):31133-31143.
  3. Goto T, Hirotsu Y, Nakagomi T, Shikata D, Yokoyama Y, Amemiya K, Tsutsui T, Kakizaki Y, Oyama T, Mochizuki H, Miyashita Y, Omata M.
    Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer.
    Oncotarget. 2017 May 24;8(45):79404-79413.
  4. Goto T, Hirotsu Y, Amemiya K, Nakagomi T, Shikata D, Yokoyama Y, Okimoto K, Oyama T, Mochizuki H, Omata M.
    Distribution of circulating tumor DNA in lung cancer: analysis of the primary lung and bone marrow along with the pulmonary venous and peripheral blood.
    Oncotarget. 2017 Jul 25;8(35):59268-59281.
  5. Iijima Y, Hirotsu Y, Amemiya K, Ooka Y, Mochizuki H, Oyama T, Nakagomi T, Uchida Y, Kobayashi Y, Tsutsui T, Kakizaki Y, Goto T, Miyashita Y, Omata M.
    Very early response of circulating tumour-derived DNA in plasma predicts efficacy of nivolumab treatment in patients with non-small cell lung cancer.
    Eur J Cancer. 2017 Nov;86:349-357.
  6. Yokoyama Y, Nakagomi T, Shikata D, Goto T.
    Combined analgesic treatment of epidural and paravertebral block after thoracic surgery.
    J Thorac Dis. 2017 Jun;9(6):1651-1657.

＜症例報告＞

  1. Goto T, Hirotsu Y, Mochizuki H, Nakagomi T, Oyama T, Amemiya K, Omata M.
    Stepwise addition of genetic changes correlated with histological change from “well-differentiated” to “sarcomatoid” phenotypes: a case report.
    BMC Cancer. 2017 Jan 19;17(1):65.
  2. Miyashita Y, Hirotsu Y, Tsutsui T, Higashi S, Sogami Y, Kakizaki Y, Goto T, Amemiya K, Oyama T, Omata M.
    Analysis of significantly mutated genes as a clinical tool for the diagnosis in a case of lung cancer.
    Respir Med Case Rep. 2017 Feb 17;20:171-175.
  3. Shikata D, Nakagomi T, Yokoyama Y, Yamada Y, Nakajima M, Oyama T, Goto T.
    Debulking surgery for venous hemangioma arising from the epicardium: report of a case.
    World J Surg Oncol. 2017 Apr 12;15(1):81.
  4. Yokoyama Y, Nakagomi T, Shikata D, Higuchi R, Oyama T, Goto T.
    Surgical treatment for mediastinal abscess induced by endobronchial ultrasound-guided transbronchial needle aspiration: a case report and literature review.
    World J Surg Oncol. 2017 Jul 14;15(1):130.
  5. Nakagomi T, Goto T, Hirotsu Y, Shikata D, Amemiya K, Oyama T, Mochizuki H, Omata M.
    Elucidation of radiation-resistant clones by a serial study of intratumor heterogeneity before and after stereotactic radiotherapy in lung cancer.
    J Thorac Dis. 2017 Jul;9(7):E598-E604.

論文業績（2018年度）

＜原著論文＞

    1. Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R, Amemiya K, Okimoto K, Oyama T, Mochizuki H, Omata M.
      New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles.
      Oncotarget. 2018 Jan 31;9(12):10635-10649.
    2. Goto T.
      What is the best pain control after thoracic surgery? J Thorac Dis.
      2018 Mar;10(3):1335-1338.
    3. Goto T, Hirotsu Y, Amemiya K, Mochizuki H, Omata M.
      Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.
      Cancers (Basel). 2018 Jun 22;10(7)
    4. Goto T.
      Measuring Surgery Outcomes of Lung Cancer Patients with Concomitant Pulmonary Fibrosis: A Review of the Literature.
      Cancers (Basel). 2018 Jul 4;10(7).
    5. Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Higuchi R, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M.
      Genomic Characteristics of Invasive Mucinous Adenocarcinomas of the Lung and Potential Therapeutic Targets of B7-H3. Cancers (Basel). 2018 Nov 30;10(12).

＜症例報告＞

  1. Shikata D, Nakagomi T, Higuchi R, Yokoyama Y, Oyama T, Goto T.
    Lymph node cancer of the mediastinum with a putative necrotic primary lesion in the lung: A case report.
    World J Surg Oncol. 2018 Apr 2;16(1):73.
  2. Higuchi R, Goto T, Nakagomi T, Oyama T.
    Surgery for congenital bronchial atresia.
    Asian Cardiovasc Thorac Ann. 2018 Jan 1:218492318780805.
  3. Higuchi R, Nakagomi T, Shikata D, Yokoyama Y, Oyama T, Goto T.
    Lingular segmentectomy and left lower lobectomy via unique bronchial dissection. J Thorac Dis. 2018 Jun;10(6):E420-E425.

論文業績（2019年度）

＜原著論文＞

  1. Otake S, Goto T. Stereotactic Radiotherapy for Oligometastasis. Cancers (Basel). 2019 Jan 23;11(2).
  2. Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review. Int J Mol Sci. 2019 Mar 18;20(6). 
  3. Kinoshita T, Goto T. Molecular Mechanisms of Pulmonary Fibrogenesis and Its Progression to Lung Cancer: A Review. Int J Mol Sci. 2019 Mar 22;20(6).
  4. Nakagomi T, Hirotsu Y, Goto T, Shikata D, Yokoyama Y, Higuchi R, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M. Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer. Cancers (Basel). 2019 Apr 17;11(4).
  5. Goto T. Is surgery the choice for treatment for first presentation of pneumothorax? J Thorac Dis. 2019 May;11(Suppl 9):S1398-S1401.
  6. Goto T. Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges. Vaccines (Basel). 2019 Aug 26;7(3).
  7. Goto T. Is local consolidative therapy adequate for the treatment of oligometastatic non-small cell lung cancer? J Thorac Dis. 2019 Oct;11(10):E154-E157.
  8. Higuchi R, Goto T, Hirotsu Y, Nakagomi T, Yokoyama Y, Otake S, Amemiya K, Oyama T, Omata M. PD-L1 Expression and Tumor-Infiltrating Lymphocytes in Thymic Epithelial Neoplasms. J Clin Med. 2019 Nov 1;8(11). 
  9. Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka SI, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M. Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model. Cancer Genet. 2019 Dec 25. pii: S2210-7762(19)30488-0.

＜症例報告＞

  1. Goto T, Arai Y, Shibata T, Oyama T, Yoshida A. Sarcoma with MGA–NUTM1 fusion in the lung: an emerging entity. Virchows Arch. 2019.
  2. Iijima Y, Hirotsu Y, Amemiya K, Higuchi R, Nakagomi T, Goto T, Uchida Y, Kobayashi Y, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M. Endotracheal or Endobronchial Metastasis of Lung Squamous Cell Carcinoma. J Bronchology Interv Pulmonol. 2019 Oct;26(4):e46-e50

論文業績（2020年度）

＜原著論文＞

  1. Kunimasa K, Goto T. Immunosurveillance and Immunoediting of Lung Cancer: Current Perspectives and Challenges. Int J Mol Sci. 2020 Jan 17;21(2).
  2.  Higuchi R, Nakagomi T, Goto T, Hirotsu Y, Shikata D, Yokoyama Y, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M. Identification of Clonality through Genomic Profile Analysis in Multiple Lung Cancers. J Clin Med. 2020 Feb 20;9(2).
  3. Hirotsu Y, Otake S, Ohyama H, Amemiya K, Higuchi R, Oyama T, Mochizuki H, Goto T, Omata M. Dual-molecular barcode sequencing detects rare variants in tumor and cell free DNA in plasma. Sci Rep. 2020 Feb 25;10(1):3391.
  4. Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. Int J Mol Sci. 2020 Feb 23;21(4).
  5. Kunimasa K, Hirotsu Y, Nakamura H, Tamiya M, Iijima Y, Ishida H, Hamamoto Y, Maniwa T, Kimura T, Nishino K, Goto T, Amemiya K, Mochizuki H, Oyama T, Nakatsuka SI, Kumagai T, Okami J, Higashiyama M, Imamura F, Omata M. Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model. Cancer Genet. 2020 Feb;241:51-56.
  6. Kunimasa K, Hirotsu Y, Amemiya K, Nagakubo Y, Goto T, Miyashita Y, Kakizaki Y, Tsutsui T, Otake S, Kobayashi H, Higuchi R, Inomata K, Kumagai T, Mochizuki H, Nakamura H, Nakatsuka SI, Nishino K, Imamura F, Kumagai T, Oyama T, Omata M. Genome analysis of peeling archival cytology samples detects driver mutations in lung cancer. Cancer Med. 2020 Jul;9(13):4501-4511.
  7. Goto T. Airway Microbiota as a Modulator of Lung Cancer. Int J Mol Sci. 2020 Apr 26;21(9):3044. 
  8. Goto T. Patient-Derived Tumor Xenograft Models: Toward the Establishment of Precision Cancer Medicine. J Pers Med. 2020 Jul 18;10(3):E64.
  9. Higuchi R, Goto T, Hirotsu Y, Yokoyama Y, Nakagomi T, Otake S, Amemiya K, Oyama T, Mochizuki H, Omata M. Primary Driver Mutations in GTF2I Specific to the Development of Thymomas. Cancers (Basel). 2020 Jul 24;12(8):E2032.

＜症例報告＞

  1. Nakagomi T, Higuchi R, Yokoyama Y, Goto T. Double Dumon Stents for Persistent Tracheoesophageal Fistula. Ann Thorac Surg. 2020 May 30:S0003-4975(20)30774-8.
  2. Oyama T, Goto T, Amemiya K, Hirotsu Y, Omata M. Squamous Cell Carcinoma of the Lung With Micropapillary Pattern. J Thorac Oncol. 2020 Jun 12:S1556-0864(20)30469-X.
  3. Kunimasa K, Hirotsu Y, Miyashita Y, Goto T, Amemiya K, Mochizuki H, Samamoto I, Ohki T, Oyama T, Honma K, Imamura F, Nishino K, Kumagai T, Omata M. Multiregional sequence revealed SMARCA4 R1192C mutant clones acquired EGFR C797S mutation in the metastatic site of an EGFR-mutated NSCLC patient. Lung Cancer. 2020 Aug 3;148:28-32.

論文業績（2021年）

原著論文

  1. Goto T. Is tomosynthesis an ingenious scheme for bronchoscopic diagnosis of lung nodules? 2021 Jan;26(1):125.
  2. Goto T. Robotic bronchoscopy: is it classic? J Thorac Dis. 2021 Jan;13(1):409-410.
  3. Goto T. Virtual-assisted lung mapping: is it actually better than finger palpation? J Thorac Dis. 2021 Jan;13(1):414-416.
  4. Kinoshita T,Goto T. Links between Inflammation and Postoperative Cancer Recurrence. J Clin Med. 2021 Jan 10;10(2):228. 
  5. Zhang J, Zhang L, Luo J, Ge T, Fan P, Sun L, Hou L, Li J, Yu H, Wu C, Zhu Y, Wu C, Jiang G, Troncone G, Malhotra J, Okuda K, Santarpia M, Zamarchi R,Goto T, Cardona AF, Xu J, Chen Q, Zhang Z, Zhang P; written on behalf of the AME Lung Cancer Collaborative Group. Comprehensive genomic profiling of combined small cell lung cancer. Transl Lung Cancer Res. 2021 Feb;10(2):636-650.
  6. Hao Z, Liang H, Zhang Y, Wei W, Lan Y, Qiu S, Lin G, Wang R, Liu Y, Chen Y, Huang J, Wang W, Cui F,Goto T, Jeong JY, Veronesi G, Lopez-Pastorini A, Igai H, Liang W, He J, Liu J. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection? Transl Lung Cancer Res. 2021 Mar;10(3):1408-1423. 
  7. Goto T. Is rigid tracheobronchoscopy safe enough for airway disease? 2021 May;26(5):507.
  8. Yokoyama Y,Goto T. Midterm outcomes of early versus late surgery for infective endocarditis with neurologic complications: a meta-analysis. J Cardiothorac Surg. 2021 Mar 25;16(1):49.
  9. Goto T. Lymph Node Dissection for NSCLC at Whose Discretion? J Thorac Oncol. 2021 Apr;16(4):e25.
  10. Higuchi R,Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Mochizuki H, Omata M. Streptococcus australisand Ralstonia pickettii as Major Microbiota in Mesotheliomas. J Pers Med. 2021 Apr 14;11(4):297.
  11. Goto T. Effect of the coronavirus disease pandemic on bronchoscopic diagnosis of lung cancer in a provincial city in Japan. J Cardiothorac Surg. 2021 Apr 28;16(1):115.
  12. Goto T. Women Fare Better After Lung-Cancer Surgery: What Does This Mean for Clinical Practice? 2021 May;159(5):2119-2120.
  13. Goto T. To Perform or Not to Perform Surgery for Frail Patients? JAMA Surg. 2021 Sep 1;156(9):890-891.
  14. Kunimasa K, Hirotsu Y, Kukita Y, Ueda Y, Sato Y, Kimura M, Otsuka T, Hamamoto Y, Tamiya M, Inoue T, Kawamura T, Nishino K, Amemiya K, Goto T, Mochizuki H, Honma K, Omata M, Kumagai T. EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors. Cancer Genet. 2021 Aug;256-257:131-135.
  15. Zhou C, Li S, Liu J, Chu Q, Miao L, Cai L, Cai X, Chen Y, Cui F, Dong Y, Dong W, Fang W, He Y, Li W, Li M, Liang W, Lin G, Lin J, Lin X, Liu H, Liu M, Mu X, Hu Y, Hu J, Jin Y, Li Z, Qin Y, Ren S, Sun G, Shen Y, Su C, Tang K, Wu L, Wang M, Wang H, Wang K, Wang Y, Wang P, Wang H, Wang Q, Wang Z, Xie X, Xie Z, Xu X, Xu F, Yang M, Yang B, Yi X, Ye X, Ye F, Yu Z, Yue D, Zhang B, Zhang J, Zhang J, Zhang X, Zhang W, Zhao W, Zhu B, Zhu Z, Zhong W, Bai C, Chen L, Han B, Hu C, Lu S, Li W, Song Y, Wang J, Zhou C, Zhou J, Zhou Y, Saito Y, Ichiki Y, Igai H, Watanabe S, Bravaccini S, Fiorelli A, Petrella F, Nakada T, Solli P, Tsoukalas N, Kataoka Y, Goto T, Berardi R, He J, Zhong N. International consensus on severe lung cancer-the first edition. Transl Lung Cancer Res. 2021 Jun;10(6):2633-2666. 
  16. Goto T. Cell-Free DNA From Nontumor Tissue in Patients With Non-small Cell Lung Cancer. 2021 Oct;160(4):e374-e375.

著書

  1. Taichiro Goto, Immunoediting and cancer priming, Cancer Immunology and Immunotherapy, Elsevier, 2021:111-136.

症例報告

  1. Chen J, Xie F, Zheng X, Li Y, Liu S, Ma KC, Goto T, Müller T, Chan ED, Sun J. Mobile 3-dimensional (3D) C-arm system-assisted transbronchial biopsy and ablation for ground-glass opacity pulmonary nodules: a case report. Transl Lung Cancer Res. 2021 Jul;10(7):3312-3319.

論文業績（2022年）

原著論文

  1. Goto T. Genomically Metastatic, but Surgically Curable?　J Thorac Oncol. 2022 Apr;17(4):e49-e50.
  1. Goto T. Beyond Personalized to “Tumoralized” Therapy.　J Thorac Oncol. 2022 Jun;17(6):e53-e54.
  1. Goto T. Comments on Intraoperative Molecular Imaging for Localizing Nonpalpable Tumors.　JAMA Surg 2022 May 1;157(5):457-458. 
  1. Higuchi R,Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Mochizuki H, Omata M.　Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors.J Pers Med. 2021 Oct 26;11(11):1092.
  1. Higuchi R, Goto T, Nakagomi T, Hirotsu Y, Oyama T, Amemiya K, Mochizuki H, Omata M. Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling.JTO Clin Res Rep. 2021 Nov 9;2(12):100255.
  1. Otake S, Goto T, Higuchi R, Nakagomi T, Hirotsu Y, Amemiya K, Oyama T, Mochizuki H, Omata M. The Diagnostic Utility of Cell-Free DNA from Ex Vivo Bronchoalveolar Lavage Fluid in Lung Cancer.Cancers (Basel). 2022 Mar 30;14(7):1764.
  1. Goto T. Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship.JAMA Oncol. 2022 Jun 1;8(6):1.
  1. Zhou C, Yang Y, Lin X, Fang N, Chen L, Jiang J, Deng H, Deng Y, Wan M, Qiu G, Sun N, Wu D, Long X, Zhong C, Xie X, Xie Z, Liu M, Ouyang M, Qin Y, Petrella F, Fiorelli A, Bravaccini S, Kataoka Y, Watanabe S, Goto T, Solli P, Igai H, Saito Y, Tsoukalas N, Nakada T, Li S, Chen R.
    Proposed clinical phases for the improvement of personalized treatment of checkpoint inhibitor-related pneumonitis.Front Immunol. 2022 Jul 20;13:935779. 
  1. Goto T. Now We Have the First Animal Model for Thymoma.J Thorac Oncol. 2022 Nov;17(11):e91-e92.　
  1. Amemiya K, Hirotsu Y, Mochizuki H, Higuchi R, Nakagomi T, Goto T, Oyama T, Kondo T, Omata M. Deep targeted sequencing of cytological tumor cells using whole genome amplification. CancerCancer Cytopathol. 2023 Jan;131(1):58-68.
  1. Goto T. Thoracic CT follow-up after non-small-cell lung cancer resection. Lancet Oncol. 2022 Nov;23(11):e485.
  1. Goto T. Microbiota and lung cancer. Semin Cancer Biol. 2022 Nov;86(Pt 3):1-10.

＜症例報告＞

  1. Nakagomi T, Goto T, Hirotsu Y, Higuchi R, Tsutsui T, Amemiya K, Oyama T, Mochizuki H, Omata M.Lung Cancer Surgery with Persistent COVID-19 Infection.Ann Thorac Surg. 2022 Aug;114(2):e79-e81.
  1. Oyama T, Goto T, Amemiya K. Mixed micropapillary patterns found in malignant pleural mesothelioma with possibly worsened prognostic implication.Thorac Cancer. 2022 Apr;13(7):1098-1099.

論文業績（2023年）

原著論文

  1. Okamoto M, Maejima M,Goto T, Mikawa T, Hosaka K, Nagakubo Y, Hirotsu Y, Amemiya K, Sueki H, Omata M. Impact of the FilmArray Rapid Multiplex PCR Assay on Clinical Outcomes of Patients with Bacteremia. Diagnostics (Basel). 2023 Jun 1;13(11):1935.
  2. Goto T.Next Generation Sequencing: the New Global Standard?J Thorac Oncol. 2023 (in press)
  1. Goto T.Kit use may not be key to improved prognosis.J Thorac Oncol. 2023 (in press)

後藤太一郎　受賞歴

2004年　Acute Lung Injury研究会　研究奨励賞

2009年　慶應義塾大学医学部　刀林賞

2017年　がん集学的治療研究財団賞

2018年　第56回 日本癌治療学会総会　優秀演題賞

2021年　Distinguished Reviewer of Translational Lung Cancer Research

　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　2021年11月2日現在

Copyright © YAMANASHI PREFECTURAL HOSPITAL ORGANIZATION All rights reserved.

ページの
先頭に戻る